Literature DB >> 3891773

Improved selective medium for the isolation of lipase-positive Clostridium botulinum from feces of human infants.

D C Mills, T F Midura, S S Arnon.   

Abstract

Isolation of lipase-positive Clostridium botulinum from fecal specimens establishes the diagnosis of infant botulism, contributes to the diagnosis of food-borne botulism, and is most easily accomplished by use of selective media. Modification of an available selective medium, C. botulinum inhibitory medium (CBI), enabled more rapid isolation of C. botulinum. The modified medium (botulinum selective medium [BSM] contained (per liter) 25 g of dehydrated heart infusion broth, 20 g of agar, 30 ml of egg yolk suspension, 250 mg of cycloserine, 76 mg of sulfamethoxazole, 4 mg of trimethoprim, and 100 IU of thymidine phosphorylase at pH 7.4. The two media were compared by using 15 fresh fecal specimens from infant botulism patients (10 type A and 5 type B) and a C. botulinum isolate that had been obtained from an infant botulism patient and that was mixed into a fresh stool specimen from a healthy human infant. In comparison to CBI, BSM always provided better suppression of the nonbotulinum fecal flora and earlier emergence of lipase-positive colonies. Diagnosis of infant botulism was accomplished sooner with BSM than with CBI because isolation of lipase-positive C. botulinum was easier.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891773      PMCID: PMC271823          DOI: 10.1128/jcm.21.6.947-950.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrimidines.

Authors:  R Ferone; S R Bushby; J J Burchall; W D Moore; D Smith
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

2.  Diagnosis and management of infant botulism.

Authors:  R O Johnson; S A Clay; S S Arnon
Journal:  Am J Dis Child       Date:  1979-06

3.  Syndrome of botulism in infancy: clinical and electrophysiologic study.

Authors:  J Pickett; B Berg; E Chaplin; M A Brunstetter-Shafer
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

4.  Cultural and physiological characteristics of Clostridium botulinum type G and the susceptibility of certain animals to its toxin.

Authors:  A S Ciccarelli; D N Whaley; L M McCroskey; D F Gimenez; V R Dowell; C L Hatheway
Journal:  Appl Environ Microbiol       Date:  1977-12       Impact factor: 4.792

5.  Infant botulism. A Pan-Pacific perspective.

Authors:  S S Arnon
Journal:  Med J Aust       Date:  1983-01-08       Impact factor: 7.738

6.  Experimental botulism in chickens: the cecum as the site of production and absorption of botulinum toxin.

Authors:  S Miyazaki; G Sakaguchi
Journal:  Jpn J Med Sci Biol       Date:  1978-02

7.  Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores.

Authors:  H Sugiyama; D C Mills
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

8.  Coproexamination for botulinal toxin and clostridium botulinum. A new procedure for laboratory diagnosis of botulism.

Authors:  V R Dowell; L M McCroskey; C L Hatheway; G L Lombard; J M Hughes; M H Merson
Journal:  JAMA       Date:  1977-10-24       Impact factor: 56.272

9.  Infant botulism. Identification of Clostridium botulinum and its toxins in faeces.

Authors:  T F Midura; S S Arnon
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

10.  Examination of prepared foods in plastic packages for Clostridium botulinum.

Authors:  C Taclindo; G S Nygaard; H L Bodily
Journal:  Appl Microbiol       Date:  1967-03
View more
  10 in total

1.  Detection and confirmation of Clostridium botulinum in water used for cooling at a plant producing low-acid canned foods.

Authors:  Amita Sachdeva; Stephanie L H Defibaugh-Chávez; James B Day; Donald Zink; Shashi K Sharma
Journal:  Appl Environ Microbiol       Date:  2010-10-01       Impact factor: 4.792

Review 2.  Update: infant botulism.

Authors:  T F Midura
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  First case of infant botulism caused by Clostridium baratii type F in California.

Authors:  Jason R Barash; Tania W H Tang; Stephen S Arnon
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments.

Authors:  D Akbulut; K A Grant; J McLauchlin
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 5.  Laboratory diagnostics of botulism.

Authors:  Miia Lindström; Hannu Korkeala
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

6.  Selection and Development of Nontoxic Nonproteolytic Clostridium botulinum Surrogate Strains for Food Challenge Testing.

Authors:  Marijke Poortmans; Kristof Vanoirbeek; Martin B Dorner; Chris W Michiels
Journal:  Foods       Date:  2022-05-27

7.  Antimicrobial Susceptibility of 260 Clostridium botulinum Type A, B, Ba, and Bf Strains and a Neurotoxigenic Clostridium baratii Type F Strain Isolated from California Infant Botulism Patients.

Authors:  Jason R Barash; Joe B Castles; Stephen S Arnon
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

8.  Combined effect of infection and heavy wrapping on the risk of sudden unexpected infant death.

Authors:  R Gilbert; P Rudd; P J Berry; P J Fleming; E Hall; D G White; V O Oreffo; P James; J A Evans
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

Review 9.  Current Developments in Diagnostic Assays for Laboratory Confirmation and Investigation of Botulism.

Authors:  Dominick A Centurioni; Christina T Egan; Michael J Perry
Journal:  J Clin Microbiol       Date:  2021-09-29       Impact factor: 11.677

10.  Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes.

Authors:  Mohammed Sebaihia; Michael W Peck; Nigel P Minton; Nicholas R Thomson; Matthew T G Holden; Wilfrid J Mitchell; Andrew T Carter; Stephen D Bentley; David R Mason; Lisa Crossman; Catherine J Paul; Alasdair Ivens; Marjon H J Wells-Bennik; Ian J Davis; Ana M Cerdeño-Tárraga; Carol Churcher; Michael A Quail; Tracey Chillingworth; Theresa Feltwell; Audrey Fraser; Ian Goodhead; Zahra Hance; Kay Jagels; Natasha Larke; Mark Maddison; Sharon Moule; Karen Mungall; Halina Norbertczak; Ester Rabbinowitsch; Mandy Sanders; Mark Simmonds; Brian White; Sally Whithead; Julian Parkhill
Journal:  Genome Res       Date:  2007-05-22       Impact factor: 9.043

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.